PROTHENA CORP PLC (PRTA) Forecast, Price Target & Analyst Ratings
NASDAQ:PRTA • IE00B91XRN20
9.73 USD
-0.04 (-0.41%)
Last: Mar 11, 2026, 02:48 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PROTHENA CORP PLC (PRTA).
Forecast Snapshot
Consensus Price Target
$20.91
+ 114.90% Upside
Next Earnings Forecast
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate-$0.37
Revenue Estimate
ChartMill Buy Consensus
75.38%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$20.91
Upside
+ 114.90%
From current price of $9.73 to mean target of $20.91, Based on 13 analyst forecasts
Low
$8.08
Median
$18.87
High
$37.80
Price Target Revisions
1 Month
0.82%
3 Months
0.82%
Price Target Summary
13 Wall Street analysts provided a forecast for the next 12 months for PRTA. The average price target is 20.91 USD. This implies a price increase of 114.9% is expected in the next year compared to the current price of 9.73.
The average price target has been revised upward by 0.82% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
75.38%
PRTA was analyzed by 13 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about PRTA.
In the previous month the buy percentage consensus was at a similar level.
PRTA was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-20 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-12-01 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-11-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-02 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-05 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-08-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-20 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2025-05-28 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2025-05-27 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-27 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-05-27 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2025-05-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-09 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-26 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-02-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-21 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate-$0.37
Revenue Estimate
Revenue Q2Q-100.00%
EPS Q2Q67.03%
Number of Analysts7
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-9.70%
EPS (3 Months)
4.74%
Next Earnings Summary
PRTA is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.37 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 91.37M 69.52% | 135.157M 47.92% | 9.684M -92.83% | 117.31M 1,111.38% | 25.5M -78.26% | 103.1M 304.31% | 102.27M -0.81% | 270.91M 164.90% | 288.91M 6.64% | 381.84M 32.17% | 446.84M 17.02% | |
| EBITDA YoY % growth | -190.108M -45.28% | -153.668M 19.17% | -183.665M -19.52% | 100.00% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -191.036M -45.16% | -154.561M 19.09% | -184.56M -19.41% | 21.845M 111.84% | -47.248M -316.29% | 41.007M 186.79% | 1.042M -97.46% | 137.53M 13,098.66% | 154.31M 12.20% | 237.75M 54.07% | 299.45M 25.95% | |
| Operating Margin | -209.08% | -114.36% | -1,905.82% | 18.62% | -185.29% | 39.77% | 1.02% | 50.77% | 53.41% | 62.26% | 67.02% | |
| EPS YoY % growth | -2.80 -11.55% | -2.30 17.86% | -3.93 -70.87% | 0.34 108.62% | -1.20 -455.23% | 0.36 129.87% | -1.24 -446.10% | 3.45 377.05% | 1.51 -56.21% | 2.50 65.88% | 2.73 8.96% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.37 67.03% | 0.50 128.65% | -0.04 94.00% | -0.41 -2.00% |
| Revenue Q2Q % growth | -100.00% | 58.656M 1,227.06% | 25.5M 955.90% | -100.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -19.533M 70.21% | 40.189M 177.28% | -16.982M 57.29% | -16.365M 39.86% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
27.88%
EPS Next 5 Year
23.54%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
109.06%
Revenue Next 5 Year
88.83%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
PROTHENA CORP PLC / PRTA Forecast FAQ
What is the price target for PRTA stock?
13 analysts have analysed PRTA and the average price target is 20.91 USD. This implies a price increase of 114.9% is expected in the next year compared to the current price of 9.73.
What is the next earnings date for PRTA stock?
PROTHENA CORP PLC (PRTA) will report earnings on 2026-05-06.
What are the consensus estimates for PRTA stock next earnings?
The consensus EPS estimate for the next earnings of PROTHENA CORP PLC (PRTA) is -0.37 USD and the consensus revenue estimate is 0 USD.
What is the consensus rating for PROTHENA CORP PLC (PRTA) stock?
The consensus rating for PROTHENA CORP PLC (PRTA) is 75.3846 / 100 . This indicates that analysts generally have a positive outlook on the stock.